Combination with third-generation bisphosphonate (YM529) and interferon-alpha can inhibit the progression of established bone renal cell carcinoma

Combination with third-generation bisphosphonate (YM529) and interferon-alpha can inhibit the progression of established bone renal cell carcinoma

The aim of this study was to investigate whether the third-generation nitrogen-containing bisphosphonate (YM529) can inhibit the progression of established bone renal cell carcinoma (RCC) and to elucidate its mechanism. Antiproliferative effect and apoptosis induction of RCC cells and mouse osteocla...

Full description

Bibliographic Details
Main Authors: Kurabayashi, Atsushi, Inoue, Keiji, Fukuhara, Hideo, Karashima, Takashi, Fukata, Satoshi, Kawada, Chiaki, Shuin, Taro, Furihata, Mutsuo
Format: Online
Language:English
Published: John Wiley & Sons, Ltd 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556400/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556400/

Similar Items